VFM
SLS icon

Vision Financial Markets’s SELLAS Life Sciences SLS Stock Holding History

Vision Financial Markets’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Sell
9,800
-294,600
-97% -$2.03M 0.13% 90
2026
Q1 		$1.29M Buy
+304,400
New +$1.36M 1.26% 15

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
FWA
Fulcrum Wealth Advisors Bellevue, Washington $131M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IW
Instrumental Wealth Tampa, Florida $198M AUM 24.07% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
VH
Visionary Horizons Knoxville, Tennessee $239M AUM 22.35% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Vision Financial Markets's SLS Position: Q2 2026 in Review

Vision Financial Markets reduced its SELLAS Life Sciences (SLS) stake by 97% in Q2 2026, selling an estimated $2.03M and leaving 9,800 shares worth $145K. The position accounts for 0.13% of the portfolio, ranked #90.

Vision Financial Markets first reported a position in SLS in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.29M in Q1 2026. 38 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Vision Financial Markets held 9,800 shares of SELLAS Life Sciences worth $145K as of Q2 2026.
  • Vision Financial Markets sold 294,600 SELLAS Life Sciences shares in Q2 2026, an estimated $2.03M.
  • SELLAS Life Sciences made up 0.13% of Vision Financial Markets's portfolio in Q2 2026, its #90 holding.
  • Vision Financial Markets first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Vision Financial Markets's SELLAS Life Sciences position peaked at $1.29M in Q1 2026.
  • 38 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.